AbbVie, AstraZeneca, Boehringer and more face FTC's ire for 'improper' patent listings
7th November 2023 Uncategorised 0 AbbVie, AstraZeneca, Boehringer and more face FTC’s ire for ‘improper’ patent listings
esagonowsky
Tue, 11/07/2023 – 14:06
More: AbbVie, AstraZeneca, Boehringer and more face FTC's ire for 'improper' patent listings
Source: fierce